West Roxbury, MA, United States of America

Yingjie Lu

USPTO Granted Patents = 20 (Patent Applications = 12)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 61(Granted Patents)

Location History:

Chestnut Hill, MA (US) (2022)
West Roxbury, MA (US) (2016 - 2024)

Company Filing History:

15 out of 1,036

Children's Medical Center Corporation

Path Vaccine Solutions

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12377140 - Multivalent pneumococcal vaccines (2025-08-05),

2. 12370247 - Multivalent pneumococcal vaccines (2025-07-29),

3. 12370246 - Immunogens and methods for discovery and screening thereof (2025-07-29),

4. 12129283 - Pneumococcal fusion protein vaccines (2024-10-29),

5. 12090198 - Combined vaccine against mycobacterium tuberculosis (2024-09-17),

6. 12083173 - Protein antigens that provide protection against pneumococcal colonization and/or disease (2024-09-10),

7. 12036276 - Multivalent pneumococcal vaccines (2024-07-16),

8. 11981708 - Multiple antigen presenting immunogenic composition, and methods and uses thereof (2024-05-14),

9. 11976097 - Modified biotin-binding protein, fusion proteins thereof and applications (2024-05-07),

10. 11701416 - Multivalent pneumococcal vaccines (2023-07-18),

11. 11576958 - Protein antigens that provide protection against pneumococcal colonization and/or disease (2023-02-14),

12. 11560410 - Modified biotin-binding protein, fusion proteins thereof and applications (2023-01-24),

13. 11305001 - Multiple antigen presenting system (MAPS)-basedvaccine, immunogenic composition, and uses thereof (2022-04-19),

14. 11235047 - Immunogens and methods for discovery and screening thereof (2022-02-01),

15. 11013793 - Multivalent pneumococcal vaccines (2021-05-25),

Title: **The Innovative Contributions of Inventor Yingjie Lu**

Introduction

Yingjie Lu is a prominent inventor based in West Roxbury, Massachusetts. With a remarkable portfolio of 17 patents, his work primarily focuses on advancements in vaccine technology, particularly in combating infectious diseases. His innovative approaches reflect his dedication to improving public health through scientific discovery.

Latest Patents

Among his most recent inventions, Yingjie Lu has developed a pneumococcal fusion protein vaccine aimed at preventing and treating pneumococcal infections. This groundbreaking technology represents a significant step forward in vaccine development. Additionally, his combined vaccine against Mycobacterium tuberculosis showcases a Multiple Antigen Presenting System (MAPS). This system involves an immunogenic composition comprising polysaccharides that stimulate immune responses. By linking peptide or polypeptide antigens with immunogenic polysaccharides using complementary affinity molecules, his work paves the way for developing vaccines that elicit robust humoral and cellular immunity.

Career Highlights

Yingjie Lu has contributed his expertise to several prestigious organizations, including Children's Medical Center Corporation and Affinivax, Inc. His career is marked by a commitment to translating complex scientific principles into effective health solutions. His extensive background in vaccine research has established him as a key player in the field of immunology.

Collaborations

Throughout his career, Yingjie has collaborated with esteemed colleagues such as Richard Malley and Fan Zhang. These collaborations have fostered an environment of innovation and exploration, undoubtedly enriching the quality of his patents and their potential impact on global health.

Conclusion

Yingjie Lu's contributions to the field of vaccine development are invaluable. His innovative patents not only reflect his expertise but also his commitment to addressing significant health challenges. As the world continues to navigate complex infectious diseases, the thoughtful inventions of inventors like Yingjie Lu will play a crucial role in enhancing public health and safety.

This text is generated by artificial intelligence and may not be accurate.